Agensys and Genentech in Cancer Antibody Agreement
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 51 (Table of Contents)
Published: 4 Sep-2004
DOI: 10.3833/pdr.v2004.i51.779 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Agensys and Genentech entered into exclusive license agreement to discover, develop and commercialize therapeutic and diagnostic products of two Agensys cancer targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS